Substituted piperazinyl acetohydrazide procaspase-activating compounds
US9663482B2 · kind B2 · utility
8Cited by
0References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 2, 2016 |
| Grant date | May 30, 2017 |
| Priority date | — |
| Expiry date | Feb 2, 2036 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/10
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention provides compounds and compositions useful for the modulation of certain enzymes. The compounds are of Formula IThe compounds and compositions can induce of cell death, particularly cancer cell death. The invention also provides methods for the synthesis and use of the compounds and compositions, including the use of compounds and compositions in therapy for the treatment of cancer and selective induction of apoptosis in cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.